Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation

被引:310
|
作者
Aghazadeh, B
Lowry, WE
Huang, XY
Rosen, MK [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Physiol & Biophys, New York, NY 10021 USA
[3] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Neurosci, New York, NY 10021 USA
[4] Cornell Univ, Weill Grad Sch Med Sci, Grad program Biochem & Struct Biol, New York, NY 10021 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
D O I
10.1016/S0092-8674(00)00085-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rho-family GTPases transduce signals from receptors leading to changes in cell shape and motility, mitogenesis, and development. Proteins containing the Dbl homology (DH) domain are responsible for activating Rho GTPases by catalyzing the exchange of GDP for GTP, Receptor-initiated stimulation of Dbl protein Vav exchange activity involves tyrosine phosphorylation, We show through structure determination that the mVav1 DH domain is autoinhibited by an N-terminal extension, which lies in the GTPase interaction site. This extension contains the Tyr174 Src-family kinase recognition site, and phosphorylation or truncation of this peptide results in stimulation of GEF activity. NMR spectroscopy data show that the N-terminal peptide is released from the DH domain and becomes unstructured upon phosphorylation. Thus, tyrosine phosphorylation relieves autoinhibition by exposing the GTPase interaction surface of the DH domain, which is obligatory for Vav activation.
引用
收藏
页码:625 / 633
页数:9
相关论文
共 28 条
  • [1] Lack of interferon-α-induced tyrosine phosphorylation of Vav proto-oncogene in patients with myelofibrosis with myeloid metaplasia
    Micouin, A
    Steunou, V
    Wietzerbin, J
    Martyré, MC
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (02) : 362 - 369
  • [2] Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice
    Mimura, T
    Minota, S
    Nojima, Y
    Morino, N
    Hamasaki, K
    Furuya, H
    Yazaki, Y
    JOURNAL OF IMMUNOLOGY, 1997, 158 (06): : 2977 - 2983
  • [3] Tyrosine phosphorylation of the vav proto-oncogene product links Fc epsilon RI to the Rac1-JNK pathway
    Teramoto, H
    Salem, P
    Robbins, KC
    Bustelo, XR
    Gutkind, JS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (16) : 10751 - 10755
  • [4] Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product
    Uddin, S
    Yetter, A
    Katzav, S
    Hofmann, C
    White, MF
    Platanias, LC
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (05) : 622 - 627
  • [5] Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95(vav), in platelets
    Cichowski, K
    Brugge, JS
    Brass, LF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) : 7544 - 7550
  • [6] The vav proto-oncogene product (p95(vav)) interacts with the Tyk-2 protein tyrosine kinase
    Uddin, S
    Sweet, M
    Colamonici, OR
    Krolewski, JJ
    Platanias, LC
    FEBS LETTERS, 1997, 403 (01) : 31 - 34
  • [7] Cross-linking of integrins induces tyrosine phosphorylation of the proto-oncogene product Vav and the protein tyrosine kinase Syk in human factor-dependent myeloid cells
    Gotoh, A
    Takahira, H
    Geahlen, RL
    Broxmeyer, HE
    CELL GROWTH & DIFFERENTIATION, 1997, 8 (06): : 721 - 729
  • [8] Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies
    Miller, M
    Ginalski, K
    Lesyng, B
    Nakaigawa, N
    Schmidt, L
    Zbar, B
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2001, 44 (01) : 32 - 43
  • [9] Cytosolic tubulin associates with the Cbl and Vav proto-oncogene products and the Syk tyrosine kinase in B cells.
    Fernandez, JA
    Peters, JD
    Keshvara, LM
    Harrison, ML
    Geahlen, RL
    FASEB JOURNAL, 1997, 11 (09): : A1055 - A1055
  • [10] Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
    Schmidt, L
    Duh, FM
    Chen, F
    Kishida, T
    Glenn, G
    Choyke, P
    Scherer, SW
    Zhuang, ZP
    Lubensky, I
    Dean, M
    Allikmets, R
    Chidambaram, A
    Bergerheim, UR
    Feltis, JT
    Casadevall, C
    Zamarron, A
    Bernues, M
    Richard, S
    Lips, CJM
    Walther, MM
    Tsui, LC
    Geil, L
    Orcutt, ML
    Stackhouse, T
    Lipan, J
    Slife, L
    Brauch, H
    Decker, J
    Niehans, G
    Hughson, MD
    Moch, H
    Storkel, S
    Lerman, MI
    Linehan, WM
    Zbar, B
    NATURE GENETICS, 1997, 16 (01) : 68 - 73